 | • レポートコード：GIR-2104Z07251 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：化学・材料 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ヒト絨毛性ゴナドトロピンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ヒト絨毛性ゴナドトロピンの種類別市場規模（天然資源抽出、組換え技術）、用途別市場規模（不妊治療診療所、研究機関、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ヒト絨毛性ゴナドトロピンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Bristol Myers Squibb、Merck & Co、Ferring、Fresenius Kabi、Sun Pharmaceutical ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：天然資源抽出、組換え技術 ・用途別分析2016年-2026年：不妊治療診療所、研究機関、その他 ・ヒト絨毛性ゴナドトロピンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ヒト絨毛性ゴナドトロピンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ヒト絨毛性ゴナドトロピンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ヒト絨毛性ゴナドトロピンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ヒト絨毛性ゴナドトロピンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Human Chorionic Gonadotropin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Human Chorionic Gonadotropin size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Human Chorionic Gonadotropin market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Human Chorionic Gonadotropin market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Natural Source Extraction
Recombinant Technology
Market segment by Application, can be divided into
Fertility Clinics
Research Institutions
Others
Market segment by players, this report covers
Bristol Myers Squibb
Merck & Co
Ferring
Fresenius Kabi
Sun Pharmaceutical
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Human Chorionic Gonadotropin
1.2 Classification of Human Chorionic Gonadotropin by Type
1.2.1 Overview: Global Human Chorionic Gonadotropin Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Human Chorionic Gonadotropin Revenue Market Share by Type in 2020
1.2.3 Natural Source Extraction
1.2.4 Recombinant Technology
1.3 Global Human Chorionic Gonadotropin Market by Application
1.3.1 Overview: Global Human Chorionic Gonadotropin Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Fertility Clinics
1.3.3 Research Institutions
1.3.4 Others
1.4 Global Human Chorionic Gonadotropin Market Size & Forecast
1.5 Global Human Chorionic Gonadotropin Market Size and Forecast by Region
1.5.1 Global Human Chorionic Gonadotropin Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Human Chorionic Gonadotropin Market Size by Region, (2016-2021)
1.5.3 North America Human Chorionic Gonadotropin Market Size and Prospect (2016-2026)
1.5.4 Europe Human Chorionic Gonadotropin Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Human Chorionic Gonadotropin Market Size and Prospect (2016-2026)
1.5.6 South America Human Chorionic Gonadotropin Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Human Chorionic Gonadotropin Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Human Chorionic Gonadotropin Market Drivers
1.6.2 Human Chorionic Gonadotropin Market Restraints
1.6.3 Human Chorionic Gonadotropin Trends Analysis
2 Company Profiles
2.1 Bristol Myers Squibb
2.1.1 Bristol Myers Squibb Details
2.1.2 Bristol Myers Squibb Major Business
2.1.3 Bristol Myers Squibb Human Chorionic Gonadotropin Product and Solutions
2.1.4 Bristol Myers Squibb Human Chorionic Gonadotropin Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Bristol Myers Squibb Recent Developments and Future Plans
2.2 Merck & Co
2.2.1 Merck & Co Details
2.2.2 Merck & Co Major Business
2.2.3 Merck & Co Human Chorionic Gonadotropin Product and Solutions
2.2.4 Merck & Co Human Chorionic Gonadotropin Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Merck & Co Recent Developments and Future Plans
2.3 Ferring
2.3.1 Ferring Details
2.3.2 Ferring Major Business
2.3.3 Ferring Human Chorionic Gonadotropin Product and Solutions
2.3.4 Ferring Human Chorionic Gonadotropin Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Ferring Recent Developments and Future Plans
2.4 Fresenius Kabi
2.4.1 Fresenius Kabi Details
2.4.2 Fresenius Kabi Major Business
2.4.3 Fresenius Kabi Human Chorionic Gonadotropin Product and Solutions
2.4.4 Fresenius Kabi Human Chorionic Gonadotropin Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Fresenius Kabi Recent Developments and Future Plans
2.5 Sun Pharmaceutical
2.5.1 Sun Pharmaceutical Details
2.5.2 Sun Pharmaceutical Major Business
2.5.3 Sun Pharmaceutical Human Chorionic Gonadotropin Product and Solutions
2.5.4 Sun Pharmaceutical Human Chorionic Gonadotropin Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Sun Pharmaceutical Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Human Chorionic Gonadotropin Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Human Chorionic Gonadotropin Players Market Share
3.2.2 Top 10 Human Chorionic Gonadotropin Players Market Share
3.2.3 Market Competition Trend
3.3 Human Chorionic Gonadotropin Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Human Chorionic Gonadotropin Revenue and Market Share by Type (2016-2021)
4.2 Global Human Chorionic Gonadotropin Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Human Chorionic Gonadotropin Revenue Market Share by Application (2016-2021)
5.2 Human Chorionic Gonadotropin Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Human Chorionic Gonadotropin Revenue by Type (2016-2026)
6.2 North America Human Chorionic Gonadotropin Revenue by Application (2016-2026)
6.3 North America Human Chorionic Gonadotropin Market Size by Country
6.3.1 North America Human Chorionic Gonadotropin Revenue by Country (2016-2026)
6.3.2 United States Human Chorionic Gonadotropin Market Size and Forecast (2016-2026)
6.3.3 Canada Human Chorionic Gonadotropin Market Size and Forecast (2016-2026)
6.3.4 Mexico Human Chorionic Gonadotropin Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Human Chorionic Gonadotropin Revenue by Type (2016-2026)
7.2 Europe Human Chorionic Gonadotropin Revenue by Application (2016-2026)
7.3 Europe Human Chorionic Gonadotropin Market Size by Country
7.3.1 Europe Human Chorionic Gonadotropin Revenue by Country (2016-2026)
7.3.2 Germany Human Chorionic Gonadotropin Market Size and Forecast (2016-2026)
7.3.3 France Human Chorionic Gonadotropin Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Human Chorionic Gonadotropin Market Size and Forecast (2016-2026)
7.3.5 Russia Human Chorionic Gonadotropin Market Size and Forecast (2016-2026)
7.3.6 Italy Human Chorionic Gonadotropin Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Human Chorionic Gonadotropin Revenue by Type (2016-2026)
8.2 Asia-Pacific Human Chorionic Gonadotropin Revenue by Application (2016-2026)
8.3 Asia-Pacific Human Chorionic Gonadotropin Market Size by Region
8.3.1 Asia-Pacific Human Chorionic Gonadotropin Revenue by Region (2016-2026)
8.3.2 China Human Chorionic Gonadotropin Market Size and Forecast (2016-2026)
8.3.3 Japan Human Chorionic Gonadotropin Market Size and Forecast (2016-2026)
8.3.4 South Korea Human Chorionic Gonadotropin Market Size and Forecast (2016-2026)
8.3.5 India Human Chorionic Gonadotropin Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Human Chorionic Gonadotropin Market Size and Forecast (2016-2026)
8.3.7 Australia Human Chorionic Gonadotropin Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Human Chorionic Gonadotropin Revenue by Type (2016-2026)
9.2 South America Human Chorionic Gonadotropin Revenue by Application (2016-2026)
9.3 South America Human Chorionic Gonadotropin Market Size by Country
9.3.1 South America Human Chorionic Gonadotropin Revenue by Country (2016-2026)
9.3.2 Brazil Human Chorionic Gonadotropin Market Size and Forecast (2016-2026)
9.3.3 Argentina Human Chorionic Gonadotropin Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Human Chorionic Gonadotropin Revenue by Type (2016-2026)
10.2 Middle East & Africa Human Chorionic Gonadotropin Revenue by Application (2016-2026)
10.3 Middle East & Africa Human Chorionic Gonadotropin Market Size by Country
10.3.1 Middle East & Africa Human Chorionic Gonadotropin Revenue by Country (2016-2026)
10.3.2 Turkey Human Chorionic Gonadotropin Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Human Chorionic Gonadotropin Market Size and Forecast (2016-2026)
10.3.4 UAE Human Chorionic Gonadotropin Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Human Chorionic Gonadotropin Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Human Chorionic Gonadotropin Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Human Chorionic Gonadotropin Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Human Chorionic Gonadotropin Revenue (USD Million) by Region (2016-2021)
Table 5. Global Human Chorionic Gonadotropin Revenue Market Share by Region (2021-2026)
Table 6. Bristol Myers Squibb Corporate Information, Head Office, and Major Competitors
Table 7. Bristol Myers Squibb Major Business
Table 8. Bristol Myers Squibb Human Chorionic Gonadotropin Product and Solutions
Table 9. Bristol Myers Squibb Human Chorionic Gonadotropin Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Merck & Co Corporate Information, Head Office, and Major Competitors
Table 11. Merck & Co Major Business
Table 12. Merck & Co Human Chorionic Gonadotropin Product and Solutions
Table 13. Merck & Co Human Chorionic Gonadotropin Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Ferring Corporate Information, Head Office, and Major Competitors
Table 15. Ferring Major Business
Table 16. Ferring Human Chorionic Gonadotropin Product and Solutions
Table 17. Ferring Human Chorionic Gonadotropin Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Fresenius Kabi Corporate Information, Head Office, and Major Competitors
Table 19. Fresenius Kabi Major Business
Table 20. Fresenius Kabi Human Chorionic Gonadotropin Product and Solutions
Table 21. Fresenius Kabi Human Chorionic Gonadotropin Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Sun Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 23. Sun Pharmaceutical Major Business
Table 24. Sun Pharmaceutical Human Chorionic Gonadotropin Product and Solutions
Table 25. Sun Pharmaceutical Human Chorionic Gonadotropin Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Global Human Chorionic Gonadotropin Revenue (USD Million) by Players (2019-2021)
Table 27. Global Human Chorionic Gonadotropin Revenue Share by Players (2019-2021)
Table 28. Breakdown of Human Chorionic Gonadotropin by Company Type (Tier 1, Tier 2 and Tier 3)
Table 29. Human Chorionic Gonadotropin Players Head Office, Products and Services Provided
Table 30. Human Chorionic Gonadotropin Mergers & Acquisitions in the Past Five Years
Table 31. Human Chorionic Gonadotropin New Entrants and Expansion Plans
Table 32. Global Human Chorionic Gonadotropin Revenue (USD Million) by Type (2016-2021)
Table 33. Global Human Chorionic Gonadotropin Revenue Share by Type (2016-2021)
Table 34. Global Human Chorionic Gonadotropin Revenue Forecast by Type (2021-2026)
Table 35. Global Human Chorionic Gonadotropin Revenue by Application (2016-2021)
Table 36. Global Human Chorionic Gonadotropin Revenue Forecast by Application (2021-2026)
Table 37. North America Human Chorionic Gonadotropin Revenue by Type (2016-2021) & (USD Million)
Table 38. North America Human Chorionic Gonadotropin Revenue by Type (2021-2026) & (USD Million)
Table 39. North America Human Chorionic Gonadotropin Revenue by Application (2016-2021) & (USD Million)
Table 40. North America Human Chorionic Gonadotropin Revenue by Application (2021-2026) & (USD Million)
Table 41. North America Human Chorionic Gonadotropin Revenue by Country (2016-2021) & (USD Million)
Table 42. North America Human Chorionic Gonadotropin Revenue by Country (2021-2026) & (USD Million)
Table 43. Europe Human Chorionic Gonadotropin Revenue by Type (2016-2021) & (USD Million)
Table 44. Europe Human Chorionic Gonadotropin Revenue by Type (2021-2026) & (USD Million)
Table 45. Europe Human Chorionic Gonadotropin Revenue by Application (2016-2021) & (USD Million)
Table 46. Europe Human Chorionic Gonadotropin Revenue by Application (2021-2026) & (USD Million)
Table 47. Europe Human Chorionic Gonadotropin Revenue by Country (2016-2021) & (USD Million)
Table 48. Europe Human Chorionic Gonadotropin Revenue by Country (2021-2026) & (USD Million)
Table 49. Asia-Pacific Human Chorionic Gonadotropin Revenue by Type (2016-2021) & (USD Million)
Table 50. Asia-Pacific Human Chorionic Gonadotropin Revenue by Type (2021-2026) & (USD Million)
Table 51. Asia-Pacific Human Chorionic Gonadotropin Revenue by Application (2016-2021) & (USD Million)
Table 52. Asia-Pacific Human Chorionic Gonadotropin Revenue by Application (2021-2026) & (USD Million)
Table 53. Asia-Pacific Human Chorionic Gonadotropin Revenue by Region (2016-2021) & (USD Million)
Table 54. Asia-Pacific Human Chorionic Gonadotropin Revenue by Region (2021-2026) & (USD Million)
Table 55. South America Human Chorionic Gonadotropin Revenue by Type (2016-2021) & (USD Million)
Table 56. South America Human Chorionic Gonadotropin Revenue by Type (2021-2026) & (USD Million)
Table 57. South America Human Chorionic Gonadotropin Revenue by Application (2016-2021) & (USD Million)
Table 58. South America Human Chorionic Gonadotropin Revenue by Application (2021-2026) & (USD Million)
Table 59. South America Human Chorionic Gonadotropin Revenue by Country (2016-2021) & (USD Million)
Table 60. South America Human Chorionic Gonadotropin Revenue by Country (2021-2026) & (USD Million)
Table 61. Middle East & Africa Human Chorionic Gonadotropin Revenue by Type (2016-2021) & (USD Million)
Table 62. Middle East & Africa Human Chorionic Gonadotropin Revenue by Type (2021-2026) & (USD Million)
Table 63. Middle East & Africa Human Chorionic Gonadotropin Revenue by Application (2016-2021) & (USD Million)
Table 64. Middle East & Africa Human Chorionic Gonadotropin Revenue by Application (2021-2026) & (USD Million)
Table 65. Middle East & Africa Human Chorionic Gonadotropin Revenue by Country (2016-2021) & (USD Million)
Table 66. Middle East & Africa Human Chorionic Gonadotropin Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Human Chorionic Gonadotropin Picture
Figure 2. Global Human Chorionic Gonadotropin Revenue Market Share by Type in 2020
Figure 3. Natural Source Extraction
Figure 4. Recombinant Technology
Figure 5. Human Chorionic Gonadotropin Revenue Market Share by Application in 2020
Figure 6. Fertility Clinics Picture
Figure 7. Research Institutions Picture
Figure 8. Others Picture
Figure 9. Global Human Chorionic Gonadotropin Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Human Chorionic Gonadotropin Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Human Chorionic Gonadotropin Revenue Market Share by Region (2016-2026)
Figure 12. Global Human Chorionic Gonadotropin Revenue Market Share by Region in 2020
Figure 13. North America Human Chorionic Gonadotropin Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Human Chorionic Gonadotropin Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Human Chorionic Gonadotropin Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Human Chorionic Gonadotropin Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Human Chorionic Gonadotropin Market Drivers
Figure 18. Human Chorionic Gonadotropin Market Restraints
Figure 19. Human Chorionic Gonadotropin Market Trends
Figure 20. Bristol Myers Squibb Recent Developments and Future Plans
Figure 21. Merck & Co Recent Developments and Future Plans
Figure 22. Ferring Recent Developments and Future Plans
Figure 23. Fresenius Kabi Recent Developments and Future Plans
Figure 24. Sun Pharmaceutical Recent Developments and Future Plans
Figure 26. Global Human Chorionic Gonadotropin Revenue Share by Players in 2020
Figure 27. Human Chorionic Gonadotropin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 28. Global Top 3 Players Human Chorionic Gonadotropin Revenue Market Share in 2020
Figure 29. Global Top 10 Players Human Chorionic Gonadotropin Revenue Market Share in 2020
Figure 30. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 31. Global Human Chorionic Gonadotropin Revenue Share by Type in 2020
Figure 32. Global Human Chorionic Gonadotropin Market Share Forecast by Type (2021-2026)
Figure 33. Global Human Chorionic Gonadotropin Revenue Share by Application in 2020
Figure 34. Global Human Chorionic Gonadotropin Market Share Forecast by Application (2021-2026)
Figure 35. North America Human Chorionic Gonadotropin Sales Market Share by Type (2016-2026)
Figure 36. North America Human Chorionic Gonadotropin Sales Market Share by Application (2016-2026)
Figure 37. North America Human Chorionic Gonadotropin Revenue Market Share by Country (2016-2026)
Figure 38. United States Human Chorionic Gonadotropin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 39. Canada Human Chorionic Gonadotropin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Mexico Human Chorionic Gonadotropin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Europe Human Chorionic Gonadotropin Sales Market Share by Type (2016-2026)
Figure 42. Europe Human Chorionic Gonadotropin Sales Market Share by Application (2016-2026)
Figure 43. Europe Human Chorionic Gonadotropin Revenue Market Share by Country (2016-2026)
Figure 44. Germany Human Chorionic Gonadotropin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. France Human Chorionic Gonadotropin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. United Kingdom Human Chorionic Gonadotropin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Russia Human Chorionic Gonadotropin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Italy Human Chorionic Gonadotropin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Asia-Pacific Human Chorionic Gonadotropin Sales Market Share by Type (2016-2026)
Figure 50. Asia-Pacific Human Chorionic Gonadotropin Sales Market Share by Application (2016-2026)
Figure 51. Asia-Pacific Human Chorionic Gonadotropin Revenue Market Share by Region (2016-2026)
Figure 52. China Human Chorionic Gonadotropin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Japan Human Chorionic Gonadotropin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. South Korea Human Chorionic Gonadotropin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. India Human Chorionic Gonadotropin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Southeast Asia Human Chorionic Gonadotropin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Australia Human Chorionic Gonadotropin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. South America Human Chorionic Gonadotropin Sales Market Share by Type (2016-2026)
Figure 59. South America Human Chorionic Gonadotropin Sales Market Share by Application (2016-2026)
Figure 60. South America Human Chorionic Gonadotropin Revenue Market Share by Country (2016-2026)
Figure 61. Brazil Human Chorionic Gonadotropin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Argentina Human Chorionic Gonadotropin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Middle East and Africa Human Chorionic Gonadotropin Sales Market Share by Type (2016-2026)
Figure 64. Middle East and Africa Human Chorionic Gonadotropin Sales Market Share by Application (2016-2026)
Figure 65. Middle East and Africa Human Chorionic Gonadotropin Revenue Market Share by Country (2016-2026)
Figure 66. Turkey Human Chorionic Gonadotropin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Saudi Arabia Human Chorionic Gonadotropin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. UAE Human Chorionic Gonadotropin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Methodology
Figure 70. Research Process and Data Source
世界のヒト絨毛性ゴナドトロピン市場規模・現状・予測（2021年-2027年） Human chorionic gonadotropin (hCG) belongs to the family of gonadotropin hormones and is naturally produced by the placenta. hCG hormone plays a pivotal role after the formation of the embryo, and hence has gained significant traction over the years for the treatment of infertility in women and men.…- 世界のヒト絨毛性ゴナドトロピン市場規模・現状・予測（2021年-2027年） Human chorionic gonadotropin (hCG) belongs to the family of gonadotropin hormones and is naturally produced by the placenta. hCG hormone plays a pivotal role after the formation of the embryo, and hence has gained significant traction over the years for the treatment of infertility in women and men.…
- 世界のヒト絨毛性ゴナドトロピン（HCG）市場 2021：企業別、地域別、種類・用途別 The Human Chorionic Gonadotropin (HCG) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- 世界のヒトパラインフルエンザウイルス診断市場規模・現状・予測（2021年-2027年） Human Papillomaviruses (HPV) are members of papillomaviridae family a group of more than 150 related viruses. These are specifically known as papillomaviruses because of some of its types give rise to a wart or papilloma which are benign growths. Some of them are also associated with certain cancers…
- 世界のヒトパラインフルエンザウイルス診断市場規模・現状・予測（2021年-2027年） Human Papillomaviruses (HPV) are members of papillomaviridae family a group of more than 150 related viruses. These are specifically known as papillomaviruses because of some of its types give rise to a wart or papilloma which are benign growths. Some of them are also associated with certain cancers…